9999999997-17-003239.txt : 20170315 9999999997-17-003239.hdr.sgml : 20170315 20170315145655 ACCESSION NUMBER: 9999999997-17-003239 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20170315 DATE AS OF CHANGE: 20170315 20170228 20170315 FILER: COMPANY DATA: COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp CENTRAL INDEX KEY: 0001082554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521984749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 000-26301 FILM NUMBER: 17690975 BUSINESS ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 MAIL ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 FORMER COMPANY: FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP DATE OF NAME CHANGE: 19990324 CT ORDER 1 filename1.pdf begin 644 filename1.pdf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end